Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parenteral hydralazine revisited

D R Powers1, P J Papadakos, J D Wallin

  • 1Department of Internal Medicine, Louisiana State University Medical Center at New Orleans, 70112, USA.

The Journal of Emergency Medicine
|April 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.

Revista espanola de anestesiologia y reanimacion·2020
Same author

Silicon optical fiber.

Optics express·2009
Same author

Additives in intravenous anesthesia modulate pulmonary inflammation in a model of LPS-induced respiratory distress.

Acta anaesthesiologica Scandinavica·2009
Same author

Effects of propofol containing EDTA on mineral metabolism in medical ICU patients with pulmonary dysfunction.

Intensive care medicine·2001
Same author

Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.

American journal of hypertension·1999
Same author

Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: the influence of long and short regimens on pregnancy rates.

Fertility and sterility·1999

Parenteral hydralazine remains a preferred vasodilator for severe preeclampsia and other hypertensive emergencies. Its efficacy and pharmacoeconomic potential are highlighted compared to other antihypertensive agents.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Development

Background:

  • Hydralazine is a vasodilator with a long history of use.
  • Understanding its pharmacology and administration is crucial for effective treatment.

Purpose of the Study:

  • To review the historical development and applications of hydralazine.
  • To emphasize the parenteral use of hydralazine in hypertensive emergencies.
  • To compare hydralazine's efficacy and cost-effectiveness with other antihypertensives.

Main Methods:

  • Literature review of historical data.
  • Pharmacological and pharmacokinetic analysis.
  • Clinical efficacy and pharmacoeconomic comparisons.

Main Results:

Related Experiment Videos

  • Parenteral hydralazine is the preferred treatment for severe preeclampsia.
  • Hydralazine demonstrates efficacy in other forms of accelerated hypertension.
  • Hydralazine presents favorable pharmacoeconomic potential.

Conclusions:

  • Parenteral hydralazine is a valuable and cost-effective option for managing severe hypertension.
  • Further consideration of hydralazine in various hypertensive conditions is warranted.